Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

Really no good reason to buy here.

The number of shares "in play" now is over 800,000,000. It's likely that the number of authorized shares will soon be increased to over one billion sooner than most expect.

It's also quite likely that a reverse split to up-list (if it happens) will be at a minimum of 1 for 50.

Anyone who thinks shorting ends with an up-listing is sadly mistaken. It actually becomes much easier to short a stock on a major exchange.

Just saying!!!

p.s. Even retail investors can short it then.